Net Cash Provided by (Used in) Operating Activities |
-327M |
USD |
-448% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
131M |
USD |
+1210% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-303M |
USD |
-131% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
25K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
25K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-499M |
USD |
-1748% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
441M |
USD |
-47.8% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
36M |
USD |
-2.7% |
Mar 31, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2022 |
Q1 2022 |
Deferred Tax Assets, Gross |
259M |
USD |
-3.72% |
Dec 31, 2023 |
Q4 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-69M |
USD |
+463% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
87M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-8M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
-14M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
50M |
USD |
-95.3% |
Dec 31, 2022 |
Q4 2022 |